Histology and Cytology Market Expected Size To Reach USD 30,543.4 Million By 2026

The global histology and cytology market was valued at USD 11,057.7 million in 2018 and is expected to reach USD 30,543.4 million by the year 2026, exhibiting a CAGR of 13.6%. Histology and Cytology procedures are related to the diagnosis of diseases and other conditions. Histology is the study of human tissues, which includes structure and function, whereas cytology is the study of human cells. Histology and cytology market had experienced a huge growth with regards to healthcare industries as several fatal diseases can be diagnosed through these clinical studies.

Currently, use of molecular techniques is a widely accepted method in histology and cytology as an enabler of morphology for diagnosing and prognosing. Moreover, the study of markers of therapeutic response has been helpful in some types of neoplasms for diagnosing cancer. There are numerous advantages in the use of cytological material to perform molecular studies: ease of obtaining fresh sample, ability to check the quality of the sample immediately after draw and better preservation of DNA and RNA. The possibility of using genomic and proteomic research in small quantities of sample obtained by fine-needle aspiration (ENA) can minimize invasive procedures and allow the monitoring of cancer, thereby increasing the demand of histology and cytology procedures. PCR, microarrays, proteomic and other sequencing methodologies are now being validated in cytological samples. Proper specimen processing is of utmost importance in maintaining morphology and nucleic acid integrity. The role of the cytopathologist is mandatory in the collection and selection of cells. Histopathology evaluation basically compares diseased or experimentally altered tissues with matching sample from healthy or control counterparts. Therefore, it is very important to rigor-ously standardize every histology process (i.e., specimen sam-pling, trimming, embedding, sectioning, and staining). Cytology allows the identification of malignancy from a small quantity of cells. Cervical Pap smears are the most widely accepted example of this kind of testing and have dramatically reduced the incidence of cervical carcinoma.

Key participants include:

Abbott Laboratories; Becton Dickinson and Company; BrandTech Scientific, Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; Southwest Precision Instruments, and Trivitron Healthcare

Get a Sample Copy of the Histology and Cytology Market Report @ https://www.reportsanddata.com/sample-enquiry-form/2194

The research segments the market based on product type, applications and end-use. It profiles the key players of the business and their individual contribution to the global economy. The report focuses on significant investments, business ventures, mergers, acquisitions, collaborations along with the technological developments in the field. It also evaluates the upcoming and niche areas in the business. The researcher aims to offer expert insights related to the industry and the new opportunities available in the market.

For this report, Reports and Data have segmented the Histology and cytology market based on type, disease type, treatment type, test type, end-use and region:

Type of Examination in Histology and Cytology market (Revenue, USD Million; 2016–2026)

Cytology
Cervical Cancer
Breast Cancer
Other Cancers
Histology

Test Type in Histology and Cytology market (Revenue, USD Million; 2016–2026)

Microscopy methods
Cytochemistry and histochemistry
Immunohistochemistry and Immunofluorescence
Flow cytometry
Molecular genetic methods
Cytogenic tests
karyotyping
fluorescent in situ hybridization (FISH)
Polymerase chain reaction
Others

End-use of Histology and Cytology market (Revenue, USD Million; 2016–2026)

Hospitals/Clinics
Biopharmaceuticals companies
Academia
Other end-users

Regional Outlook (Revenue in USD Million; 2020–2026)

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)

Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/2194

Further key findings from the report suggest

Histology and cytology market had experienced a huge growth in the healthcare industry as several fatal diseases can be diagnosed through these clinical studies.

Roche launched the VENTANA DP 200 slide scanner which is a high-speed slide scanner for digital pathology in March 2018. It reduces workflow errors and improves image quality. Such product launches are expected to drive histology and cytology market.

Cytology testing attributed to large disease prevalence and adoption of the test for cervix screening. The segment can maintain its leading position during the forecast period due to the recent entry of various tests and advantages over histology such as faster analysis and cost-effectiveness.

Flow Cytometry sub-segment was expected to show the maximum CAGR during the forecast period within the test type segmentation of the histology and cytology. This segment is used to detect and measure characteristics of cell mainly used in laboratories which contribute to the market growth of this product segment.

The histology and cytology market will prove advantageous to the Asia-Pacific region to a great extent. It’s CAGR was the highest amongst all regions during the forecast period.The major factor driving the growth of this market is the huge population density in countries like India and China and increasing awareness about these tests.

In September 2018, Phillips launched computational pathology software, Tissue Mark, for automated ovarian and prostate tumor detection, which provides doctors and lab technicians with an effective histology and cytology diagnosis tool…Continued

Buy now@ https://www.reportsanddata.com/checkout-form/2194

Reasons to buy Histology and Cytology Market Report: –

Information provided in the report assists companies in making well-informed executive decisions with a comprehensive understanding of the Histology and Cytology market scenario and trends.

Assists companies in implementing lucrative expansion strategies by offering information relating to the projected fluctuations in sales performance and supplier prices.

Enables IT enterprises in capitalizing on the latest market trends and accurate insights into the Histology and Cytology Market, arming them with essential information and other significant concerns of the industry.

It allows readers to make favorable investments by tracing the substantial focus areas highlighted by survey takers in 2018.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/histology-and-cytology-market

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.